Safety and efficacy of Muscular-Tunneling Peroral Endoscopic Septotomy (MT-POES) for the treatment of Zenker’s diverticulum
Endoscopy · 01.04.2024 · 56 (S 02 S 02) · S182
DOI: 10.1055/s-0044-1783098 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endoscopy, erschienen am 01.04.2024. Verfasst von M. Spandre und 9 weiteren Autor:innen. Die Arbeit nennt 1 Literaturangaben.
Abstract (Originalsprache)
Aims
This observational study aims to evaluate the technical success, clinical efficacy, and safety of a Peroral Endoscopic Septotomy (POES) variant, named Muscular Tunnelling Peroral Endoscopic Septotomy (MT-POES), for the treatment of Zenker's diverticulum (ZD).
Methods
This study included 32 patients with symptomatic ZD, naïve to previous treatments, treated with MT-POES in our Centre between March 2021 and September 2023. Mean diverticular size was 30 mm (IQR=20 – 36.3). Endpoints of the study included technical success, clinical efficacy (objectified by a reduction in mean Dakkak-Bennet dysphagia score) and safety of the procedure. The first stage of MT-POES is performing a longitudinal mucosotomy on the top of the septum in order to expose the cricopharyngeal muscle. Then, unlike in the standard POES where the muscle is isolated by creating two lateral submucosal tunnels, a direct muscular dissection is carried out, creating an intra-septal muscular tunnel, which extends approximately 5-10 mm in the oesophageal wall, in order to ensure a complete septal myotomy. Finally, the mucosotomy is sealed using through-the-scope clips.
Results
MT-POES demonstrated a 100% technical success rate, with a median procedural time of 40 minutes (range 15-90 min), recording a shortening of time from the first to the second half of the casuistry. Median pre-treatment Dakkak-Bennet score was 2 (IQR=1 – 2). After the treatment 94% (30/32) of patients achieved complete resolution of the symptom. One patient was not fully satisfied and requires an additional treatment with Flexible Endoscopic Septum Division (FESD), with no residual dysphagia. One patient experienced a relapse of dysphagia after three symptoms-free months and was successfully treated with FESD. Mean follow up time was 11.5 months (IQR 5 – 14). No major adverse events were reported. Four patients (12.9%) developed subclinical self-limiting pneumomediastinum. Median hospital stay was two days. [ 1 ]
Conclusions
MT-POES is a safe and effective therapeutic option for symptomatic ZD, exhibiting promising outcomes in terms of technical success, dysphagia relief and safety, comparable to those reported in other studies of Peroral Endoscopic Myotomy (Z-POEM) and POES. Further studies and longer follow-up are needed to confirm the validity of this technique. Publication History Article published online: 15 April 2024 © 2024. European Society of Gastrointestinal Endoscopy. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
Zitieren
APA
Spandre, M., Testa, G., Frigo, F., Roma, M., Garripoli, A., Giudici, G., Terra, M. A. L., Sapone, N., Coppola, F., & Arese, D. (2024). Safety and efficacy of Muscular-Tunneling Peroral Endoscopic Septotomy (MT-POES) for the treatment of Zenker’s diverticulum. Endoscopy, 56(S 02 S 02), S182. https://doi.org/10.1055/s-0044-1783098
Vancouver
Spandre M, Testa G, Frigo F, Roma M, Garripoli A, Giudici G, et al. Safety and efficacy of Muscular-Tunneling Peroral Endoscopic Septotomy (MT-POES) for the treatment of Zenker’s diverticulum. Endoscopy. 2024;56(S 02 S 02):S182. doi:10.1055/s-0044-1783098
BibTeX
@article{Spandre2024,
author = {Spandre, M. and Testa, G. and Frigo, F. and Roma, M. and Garripoli, A. and Giudici, G. and Terra, M. A. La and Sapone, N. and Coppola, F. and Arese, D.},
title = {Safety and efficacy of Muscular-Tunneling Peroral Endoscopic Septotomy (MT-POES) for the treatment of Zenker’s diverticulum},
journal = {Endoscopy},
year = {2024},
volume = {56},
number = {S 02 S 02},
pages = {S182},
doi = {10.1055/s-0044-1783098}
}
EUVIMED